Filana Therapeutics, Inc. Other Current Assets
Filana Therapeutics, Inc. (FLNA) had Other Current Assets of $220.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-05-07
- 2026-03-31: Other Assets, Current $220.00K.
- 2025-12-31: Other Assets, Current $64.00K.
- 2025-09-30: Other Assets, Current $106.00K.
- 2025-06-30: Other Assets, Current $134.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-03-31 | $220.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $64.00K 10-Q · filed 2026-05-07 |
| 2025-09-30 | $106.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $134.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $162.00K 10-Q · filed 2025-05-08 |
| 2024-12-31 | $38.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $192.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $161.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $218.00K 10-Q · filed 2024-05-10 |
| 2023-12-31 | $287.00K 10-K · filed 2025-03-03 |
| 2023-09-30 | $189.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $287.00K 10-Q · filed 2024-08-08 |
| 2022-12-31 | $160.00K 10-K · filed 2024-02-28 |
| 2021-03-31 | $1.57M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $488.00K 10-Q · filed 2021-04-29 |
| 2020-09-30 | $997.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $186.00K 10-Q · filed 2020-08-12 |
| 2020-03-31 | $277.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $268.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $385.00K 10-Q · filed 2019-10-29 |
| 2019-06-30 | $49.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $140.00K 10-Q · filed 2019-05-02 |
| 2018-12-31 | $233.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $276.00K 10-Q · filed 2018-10-30 |
| 2018-06-30 | $91.00K 10-Q · filed 2018-07-26 |
| 2018-03-31 | $155.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $184.00K 10-K · filed 2019-03-29 |
| 2017-09-30 | $288.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $12.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $126.00K 10-Q · filed 2017-04-26 |
| 2016-12-31 | $356.00K 10-K · filed 2018-02-06 |
| 2016-09-30 | $456.00K 10-Q · filed 2016-10-26 |
| 2016-06-30 | $115.00K 10-Q · filed 2016-07-19 |
| 2016-03-31 | $299.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $392.00K 10-K · filed 2017-03-07 |
| 2015-09-30 | $520.00K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $200.00K 10-Q · filed 2015-07-23 |
| 2015-03-31 | $119.00K 10-Q · filed 2015-05-08 |
| 2014-12-31 | $239.00K 10-K · filed 2016-03-03 |
| 2014-09-30 | $358.00K 10-Q · filed 2014-11-05 |
| 2014-06-30 | $482.00K 10-Q · filed 2014-08-06 |
| 2014-03-31 | $141.00K 10-Q · filed 2014-05-07 |
| 2013-12-31 | $265.00K 10-K · filed 2015-02-18 |
| 2013-09-30 | $389.00K 10-Q · filed 2013-11-01 |
| 2013-06-30 | $3.00K 10-Q · filed 2013-08-01 |
| 2013-03-31 | $127.00K 10-Q · filed 2013-04-24 |
| 2012-12-31 | $253.00K 10-K · filed 2014-02-05 |
| 2012-09-30 | $378.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $95.00K 10-Q · filed 2012-08-02 |
| 2012-03-31 | $475.00K 10-Q · filed 2012-05-08 |
| 2011-12-31 | $358.00K 10-K · filed 2013-02-08 |
| 2011-09-30 | $493.00K 10-Q · filed 2011-11-03 |
| 2011-06-30 | $15.00K 10-Q · filed 2011-08-04 |
| 2010-12-31 | $144.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |